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Osteopenia and osteoporosis are bone disorders characterized by reduced bone
mineral density (BMD), altered bone microarchitecture and increased bone fragility.
Because of global aging, their incidence is rapidly increasing worldwide and novel
treatments that would be more efficient at preventing disease progression and at
reducing the risk of bone fractures are needed. Preclinical studies are today a major
bottleneck to the collection of new data and the discovery of new drugs, since they are
commonly based on rodent in vivo systems that are time consuming and expensive, or
in vitro systems that do not exactly recapitulate the complexity of low BMD disorders.
In this regard, teleost fish, in particular zebrafish and medaka, have recently emerged
as suitable alternatives to study bone formation and mineralization and to model human
bone disorders. In addition to the many technical advantages that allow faster and larger
studies, the availability of several fish models that efficiently mimic human osteopenia
and osteoporosis phenotypes has stimulated the interest of the academia and industry
toward a better understanding of the mechanisms of pathogenesis but also toward
the discovery of new bone anabolic or antiresorptive compounds. This mini review
recapitulates the in vivo teleost fish systems available to study low BMD disorders and
highlights their applications and the recent advances in the field.
Keywords: teleosts, fish model, induced osteoporosis, screening, bone anabolic compounds
INTRODUCTION
Osteoporosis (OP) is an age-related metabolic disease characterized by low bone mineral density
(BMD), the deterioration of bone architecture and the occurrence of fragility fractures (reviewed
in Compston et al., 2019). Its prevalence is increasing worldwide, and it is likely that the steady
increase in life expectancy will aggravate this already worrying situation. Current treatments mostly
rely on anti-resorptive drugs (Tu et al., 2018) that are also associated with limited long-term efficacy
and critical side effects, highlighting the importance to search for new therapeutics. Alternative
therapies based on new technologies like mesenchymal stem cells and reverse genetics using
sncRNAs and miRNAs (reviewed in De Martinis et al., 2019) are being developed. However, much
of the research effort is nowadays concentrated on the discovery of bone anabolic agents that would
promote proliferation/differentiation of osteoblasts (Chen M. et al., 2014) or increase bone mineral
deposition to counteract BMD reduction. The discovery and development of osteogenic drugs
require not only a deep understating of OP molecular players but also high-throughput screening
pipelines that can identify compounds in large molecule libraries. Despite metabolic and anatomic
differences with humans, ovariectomized rodents have become a reference model for OP research
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and early stage testing of compounds (Turner, 2001; van‘t Hof,
2011; Sophocleous and Idris, 2014; Komori, 2015), but issues
related to costs and low screening throughput have limited their
use in particular areas of OP studies. The growing interest in fish
species to model human diseases (Schartl, 2014), in particular
zebrafish and medaka, and their validation as suitable alternatives
to study human skeletal disorders (reviewed in Laizé et al., 2014;
Witten et al., 2016; Carnovali et al., 2019a; Tonelli et al., 2020),
has contributed to favor their use to address OP pathophysiology
(reviewed in Bergen et al., 2019). The development of fish OP
models that respond to classical anti-OP drugs gave rise to new
tools to accelerate bone research and to test and characterize
new drugs for OP treatment. In this review, we will provide
an overview of these models, their suitability as systems for
phenotype-based screenings and the advantages of using these
small non-mammalian vertebrates, as well as their applications,
in the study of osteoporosis.
SUITABILITY OF TELEOST FISH TO
STUDY OSTEOPOROSIS
Small teleost fish such as zebrafish and medaka have been
increasingly used as models for human skeletal diseases as they
hold many anatomic and developmental features of mammalian
skeletons (reviewed in Laizé et al., 2014; Witten et al., 2016;
Carnovali et al., 2019a; Tonelli et al., 2020). Teleostean and
mammalian axial and appendicular skeletons are similar in
many aspects: nearly all the bones are matching and genes, cells
and mechanisms controlling skeletogenesis, including the early
formation of the cartilaginous anlage and its replacement by
bone, through endochondral and perichondral ossification, and
the dermal ossification processes, are highly conserved (Javidan
and Schilling, 2004; Hall, 2015). Importantly, 70% of human
genes have at least one ortholog in zebrafish and medaka genomes
(Kasahara et al., 2007; Sasaki and Shimizu, 2008; Howe et al.,
2013). In addition, the amenability of this two fish models
to genetic manipulation/editing, e.g., through CRISPR/cas9
technology (Hwang et al., 2013; Ansai and Kinoshita, 2014;
Kirchmaier et al., 2015; Cornet et al., 2018) have favored the
development of several mutant lines capable of modeling human
skeletal disorders. Other features such as a high number of
offspring, a short generation time, an external development and
translucent early life stages have potentiated the popularity of
these two teleosts for bone studies. However, differences exist
and those must be considered when using fish as models for OP
studies. In this regard, osteocytes, which represent nearly 95% of
all bone cells in mammals (Franz-Odendaal et al., 2006) and have
been linked to bone loss in OP patients (Busse et al., 2010), are
not present in all life stages and/or skeletal elements of teleosts
(Witten and Huysseune, 2009; Apschner et al., 2011). In medaka,
bone is totally devoid of osteocytes, while osteocytes are absent
from zebrafish bone during early development and in exoskeletal
structures such as scales and fins rays. Despite the absence
of osteocytes, teleost bone is still subjected to resorption and
remodeling (Witten and Huysseune, 2009) and is still responsive
to mechanical loading (Suniaga et al., 2018; Ofer et al., 2019).
Osteoclasts, the bone resorbing cells, are also slightly different.
Large multinucleated cells in mammals, they are often small
mononucleated cells in teleosts; however, resorbing activity is
maintained (although lower in teleosts) and molecular pathways
are conserved (Witten and Huysseune, 2009). It is worth to note
that teleost fins and scales are dermal skeletal elements with no
corresponding structures in mammals as they were largely lost
during terrestrial evolution and replaced by non-calcified hair
and feathers or keratin derived scales and horns; thus care should
be taken when comparing results collected from these systems
with those from human trabecular or compact bone.
GLUCOCORTICOID INDUCED
OSTEOPOROSIS
Glucocorticoids (GCs) are potent immunosuppressive drugs used
to treat inflammatory diseases; however, long-term therapies lead
to complex adverse effects, including secondary osteoporosis.
In humans, GCs impact bone metabolism by decreasing
bone formation and vascularization and increasing bone
resorption (reviewed in Chotiyarnwong and McCloskey, 2020).
In conditions of glucocorticoid-induced osteoporosis (GIOP),
osteoblasts experience increased apoptosis and have their activity
and number reduced. Additionally, osteoclast proliferation,
lifespan, and activity are increased in the initial phase of GIOP.
Longer treatments, however, impair osteoclast formation and
function (Buehring et al., 2013). Much remains to be elucidated
on the mechanisms underlying osteoporosis and, today, no
effective treatment for GIOP has been developed. Mammalian
models mimicking GIOP (reviewed in Wood et al., 2018) have
been preferentially used to uncover important pathophysiological
aspects of the disease, although small teleost fish, such as
zebrafish and medaka, were shown to respond in a similar way
to GC treatment, confirming the evolutionary conservation of
key players and pathways in GC metabolism, and represent a
valuable option for the study of GIOP (Table 1). Barrett and
colleagues demonstrated that tissue ossification was reduced in
zebrafish larvae exposed to prednisolone and that phenotype
could be partially rescued upon treatment with bisphosphonates
(Barrett et al., 2006), a key similarity to human GIOP (Hayat and
Magrey, 2020). Still in zebrafish larvae, resveratrol was shown to
counteract the OP phenotype induced by dexamethasone (Luo
et al., 2019), as described for mammals (Tou, 2015). Further
studies aiming at validating the suitability of the fish model
have evidenced an effect of prednisolone on bone homeostasis,
through the altered expression of genes (i) involved in osteoblast
(entpd5a) and osteoclast (acp5a and sost) differentiation, (ii)
crucial to extracellular matrix (ECM) mineralization (mmp9 and
mmp13), and (iii) involved in pathways critical to osteoblast
and osteoclast signaling (Huo et al., 2018). Adult zebrafish
models have also been used to study GIOP. Because scales
can be harvested from adult zebrafish with little or no stress
and have the capacity to fully regenerate in 2 weeks, they are
commonly used for in vivo and ex vivo bone research. Treatment
of zebrafish with prednisolone during scale regeneration was
shown to induce an osteoporotic phenotype in regenerates, due
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to an imbalanced bone formation. Scales of OP fish displayed
an enhanced osteoclast activity, an increased matrix resorption
and induced osteoporotic gene-expression profile in osteoblasts
and osteoclasts (de Vrieze et al., 2014). It was additionally
shown that prednisolone-treated zebrafish exhibited increased
resorption lacunae and lower osteoblastic function, evidenced
by decreased alkaline phosphatase (ALP) activity, and that
concomitant treatment with alendronate restored ALP activity
and significantly decreased tartrate-resistant acid phosphatase
(TRAP) activity, a proxy for osteoclast function (Pasqualetti et al.,
2015). In scales of male zebrafish, age was shown to potentiate
the effect of prednisolone treatment, further increasing TRAP
activity, tnfrsf1b expression, and the extent of the resorption
lacunae (Carnovali et al., 2020a). Bony rays of zebrafish caudal
fin were also found to be a suitable and reliable model to
study the elemental, structural and mechanical characteristics
of bones affected by anti- and pro-mineralogenic compounds.
Exposure of zebrafish to prednisolone during fin ray de novo
formation delayed bone growth and impaired bone regeneration
by impacting on the number, activity and differentiation of
osteoblasts and osteoclasts, but also immune cells (Geurtzen
et al., 2017). Moreover, prednisolone altered the expression of
several ECM related genes and continued exposure deteriorated
cellular trafficking in the regenerating fin thus interfered with
epithelial and bone tissue restoration upon amputation (Schmidt
et al., 2019). Again, alendronate was able to prevent prednisolone
effects on fin ray mineralization and calcium/phosphorous levels,
and restored bone biomechanical properties (Bohns et al., 2020).
There is, however, a striking difference between humans and
zebrafish, when it comes to vertebrae, as adult zebrafish vertebrae
are not affected by GC-induced bone loss. This could be
partially explained by the low rates of osteoblast proliferation
as GC treatment seems to have greater impact on bone tissues
undergoing active osteoblast proliferation (Geurtzen et al., 2017).
HIGH GLUCOSE AND HIGH FAT
INDUCED OSTEOPOROSIS
Diabetes is a chronic metabolic disease that is growing worldwide
(Lin et al., 2020). It has a negative impact on many tissues/organs,
including the skeleton, where it may trigger or potentiate the
development of osteoporosis (Cipriani et al., 2020). Together,
diabetes and osteoporosis are responsible for severe clinical
complications that impact on patients’ quality of life and
impose an important economic burden to health systems
(Leung et al., 2017). Epidemiologic studies have also evidenced
positive associations between obesity and bone health (Zhao
et al., 2007) and an interplay between type 2 diabetes and
overweight (reviewed in Al-Goblan et al., 2014). Although recent
studies have evidenced interactions between bone and glucose
or fat metabolism, much remains to be understood concerning
the molecular players and their interaction with genetics and
environment. Because it has become a widespread model to
investigate metabolic diseases such as diabetes and obesity (Zang
et al., 2018; Carnovali et al., 2019b; and references therein) and
skeletal pathologies (Tonelli et al., 2020 and references therein),
zebrafish is therefore a model of choice to investigate the interplay
between hyperglycemia/obesity and bone, under pathological
conditions (Table 1). In humans, chronic hyperglycemia is
known to negatively affect bone homeostasis resulting in
increased bone fragility, reduced mechanical strength and
increased fracture risk due to impaired ECM formation and bone
cells function (Cipriani et al., 2020). In a zebrafish model of
diabetes [Tg(ins:nfsb-mCherry)], it was shown that both larval
osteogenesis and the regenerative capacity of caudal fin rays was
impaired under hyperglycemia, and that this condition can be
rescued by treatment with the vitamin D analog (paricalcitol) and
a calcimimetic (cinacalcet) (Carvalho et al., 2017). Additionally,
studies using adult zebrafish exposed to glucose have revealed
a decrease in scale matrix mineralization, the presence of bone
resorption lacunae associated with an intense osteoclast activity
and altered expression of bone regulatory genes (Carnovali et al.,
2016a, 2019b), similarly to what has been recently reported in
bones of diabetic rodents (An et al., 2019) and humans (Karner
and Long, 2018). The presence of bone resorption lacunae
associated with intense osteoclastic TRAP activity and decreased
osteoclastic ALP activity was also observed in the scales of
adult zebrafish fed a high-fat diet and showing signs of obesity
(Carnovali et al., 2018).
IRON OVERLOAD INDUCED
OSTEOPOROSIS
Iron plays an essential role in human physiology as a co-
factor in biochemical reactions involved in critical metabolic
functions such as oxygen transport and storage, respiratory
chain complexes and DNA replication (Frazer and Anderson,
2014; Bogdan et al., 2016). Aging has been associated with iron
accumulation in different tissues and the production of reactive
oxygen species (ROS; reviewed in Picca et al., 2019), which
contribute to promote or potentiate the severity of age associated
pathologies such as osteoporosis and osteoarthritis (Liu et al.,
2006). Excess of iron also promotes osteoclast differentiation in
mouse and increased bone resorption (Camacho et al., 2016;
Simão et al., 2018, 2019). In zebrafish larvae, iron overload
inhibited bone formation and decreased expression of osteoblast
marker genes, allegedly due to an increased ROS production
and the associated oxidative stress (Chen B. et al., 2014). Larvae
of the zebrafish mutant expressing a defective Ferroportin 1,
a cellular iron exporter required for iron cycling, exhibited, in
addition to severe hypochromic anemia, clear defects in bone
formation, including a reduced number of calcified vertebrae
and the abnormal expression of osteoblastic genes (Bo et al.,
2016). High-iron stress was also used to promote an osteoporosis-
like phenotype in zebrafish (Zhang W. et al., 2018; Table 1).
Both larvae and adult fish showed a significant decrease in bone
mineralization and severe developmental defects in cartilage
formation. Interestingly, defective osteogenesis was significantly
rescued using alendronate, a drug known to be effective against
human osteoporosis by targeting the Bmp signaling pathway and
promoting osteoblast differentiation (Zhang S. et al., 2018).

















TABLE 1 | List of teleost models and respective assays to mimic mammalian osteopenic/osteoporotic phenotypes.
Model Species Life stage Bone structure Induction
(treatment; duration)






Zebrafish Larvae Whole skeleton PN 25 µM; 5–10 dpf Reduced mineralized area
and bone mass density in
skull bones





PN 25 µM; 5–10 dpf Decreased osteoblast signaling; increased osteoclast
signaling; altered expression of focal adhesion and
ECM-receptor genes
N/A Huo et al., 2018
PN 25 µM; 5–15 dpf Disrupted expression of osteoblast, osteoclast, and
ECM-related genes
He et al., 2018




DX 10 µM; 3–9 dpf Reduced Ca and P content; down-regulated
hydroxy-proline; decreased Alp activity; increased
Trap activity; decreased expression of osteoblast and
ECM genes
AC 0.1 µg/mL; concomitant Yin et al., 2019
DX 15 µM; 3–9 dpf Reduced osteoblast differentiation RV 25–250 µM; concomitant Luo et al., 2019
DX 20 µM; 3–11 dpf Reduced expression of osteoblast genes; increased
oxidative stress levels
RC 6 × 10−6 µg/mL;
concomitant
Luo S. et al.,
2016; Luo S. Y.
et al., 2016
Adult Scales PN 25 µM; 21 dpr Impaired mineralization in
mis-shaped regenerated
scales
Enhanced osteoclast activity and matrix resorption;
altered Ca/P molar ratio; time shifted expression of
osteoblast and osteoclast genes
N/A de Vrieze et al.,
2014
PN 50 µM; 15 dpr Loss of bone matrix and
reduced repair of resorption
lacunae
Decreased Alp activity; increased Trap activity AL 30 µM; concomitant Pasqualetti
et al., 2015
PN 80 µM; 14 d Higher resorption lacunae in
aged scales
Increased Trap activity and increased expression of
tnfsf11 in aged scales; higher increase shown for
aged-treated scales
N/A Carnovali et al.,
2020a
Fin PN 50 µM; 6 w Impaired bone formation N/A N/A Geurtzen et al.,
2017
PN 125 µM; 14 d Reduced mineralized tissue
density
Reduced Ca/P molar ratio; declined bone mechanical
proprieties (reduced elastic modulus and hardness)
AL 30 µM; 21 dpa Bohns et al.,
2020
PN 50 µM; 4 dpa N/A Altered ECM composition; impaired ion and
macromolecular transport mechanisms
N/A Schmidt et al.,
2019
PN 50 µM; 14 dpa Shorter regenerates with
reduced mineralization of
bone matrix
Impaired osteoblast proliferation differentiation;
reduced bone-forming activity; reduced number of
osteoclasts and impaired migration; increased





Skull PN 50 µM; 14 dpi Delayed bone regeneration Impaired osteoblast function; reduced number of
macrophages
Medaka Adult Pharyngeal bones PN 50 µM; 32 d Defective pharyngeal teeth
and bone structures















































TABLE 1 | Continued
Model Species Life stage Bone structure Induction
(treatment; duration)








Vertebrae HS 2 h 39◦C; 9/21 dpf Severe bone matrix
degradation in the vertebral
column and other bone
structures
Formation of ectopic osteoclasts in intervertebral
regions, migration toward the mineralized vertebral
bodies/arches and contact with resident osteoblasts
ET 5–15 µg/mL,
AL 25–75 µg/mL, 9–11 dpf
To et al., 2012;
Yu et al., 2016;
Yu and Winkler,
2017
HS 2 h 39◦C; 9 dpf Differentiation of ectopic macrophages into
osteoclasts; reduced macrophage dynamics;
decreased expression of cytokine receptor genes;
increased bone-resorption and osteoblast
differentiation by macrophages






Scales Glucose 4%; 28 d Extended bone loss and
resorption lacunae in
mis-shaped scales
Higher glycaemia; increased advanced glycation end
products; decreased Alp activity; increased Trap
activity
N/A Carnovali et al.,
2016a
Adult Glucose 4%; 4 w Increased resorption lacunae Decreased Alp activity; increased Trap activity; altered
expression of bone regulatory genes








Opercular bone MET 0.05 M Reduced operculum growth Down regulation of bone regulatory genes (sp7,
bglap) and insulin pathway genes (insa, insb insra)
CA 0.001 µg/mL,
PC 0.001 µg/mL, CI 0.05 µg/mL;
3 d after OP induction
Carvalho et al.,
2017




Zebrafish Obese adult Scales Fed ad libitum
3 times/day; 7 w
Increased resorbed borders Impaired insulin production in β-cells; abnormal
adiponectin and leptin blood levels; imbalanced fat
metabolism; decreased Alp activity; increased Trap
activity




Zebrafish Larvae Whole skeleton FAC 10–100 µg/mL;
2–6 dpf
Decreased mineralization in
vertebrae and skull bones
Impaired bone formation from decreased expression
of osteoblast-specific genes; increased osteoclast
differentiation and bone resorption through ROS
production




Severe developmental cartilage defects;
downregulated expression of osteoblast and
cartilage-specific markers
AL (unk. conc.); 2–10 dpf Zhang W. et al.,
2018
Adult FAC 500 µg/mL; 15 d Reduced BMD in vertebrae,
pelvic, and caudal fins






Vertebrae No treatment; 2 dpf Decreased bone calcification Development of severe hypochromic anemia;
impaired osteoblasts differentiation and mineralization;
decreased expression of genes involved in BMP
signaling pathway







































TABLE 1 | Continued
Model Species Life stage Bone structure Induction
(treatment; duration)





Zebrafish Larvae Whole skeleton Clinorotation 60 rpm;
5–10 dpf
Reduced ossification in skull No alterations in cartilage formation; Reduced
osteoblastic differentiation/activity by altered gene
expression in the FOS–JUN transcription factor
complex and the cAMP-responsive Creb1/Crem
pathway




Skull RVW 18.5 rpm; 10 hpf












larvae and malformations in
juveniles/adults
Delayed cell migration and/or differentiation Franz-Odendaal
and Edsall,
2018
Medaka Larvae Juveniles Cranial SF; 6–9 d N/A Enhanced osteoblast signals; increased acp5/mmp9




Medaka Adults Pharyngeal bones
and vertebrae
SF; 56 d Reduced BMD Decreased collagen levels; decreased expression of
osteoblast marker genes; increased Trap activity; low






Zebrafish Larvae Whole skeleton PTH 30 ng/mL; 9 d Decreased mineralization in
skull bones




Zebrafish Adult Caudal fin BTx-B; 0.1–0.5 U Impaired mineralization in
regenerated bone
Altered bone ray segment morphology, branching,
and joint specification; impaired crystalline mineral
accumulation; altered sonic-hedgehog genes
expression





Zebrafish Adult Vertebrae RM; 35 d Abnormal vertebral column
and reduced BMD
Asymmetrical and mis-shaped vertebrae; reduced
intervertebral space; reduced bone volume
N/A Khajuria and
Karasik, 2020
GC, glucocorticoid; PN, prednisolone; DX, dexamethasone; AL, alendronate; ET, etidronate; AC, alfacalcidol; RV, revesterol; RC, rocalirol; CA, calcitriol; PC, Paricalcitol; CI, cinacalcet; RWV, rotating wall vessel; SF,
space flight; PTH, parathyroid hormone; BTx-B, type B Botulinum toxin; PTx, Pertussis toxin; FAC, ferric ammonium citrate; MET, metronidazole; DFO, deferoxamine; DX, dextran iron; Alp, alkaline phosphatase;
Trap, tartrate-resistant acid phosphatase; ROS, reactive oxygen species; BMD, bone mass density; N/A, not applicable; hpf, hours post-fertilization; dpf, days post-fertilization; dpa, days post-amputation; dpr, days
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RANKL-OVEREXPRESSION INDUCED
OSTEOPOROSIS
Receptor activator of NF-κB ligand (RANKL) and its receptor
RANK play a pivotal role in the differentiation of cells of
the monocyte/macrophage lineage into functional osteoclasts
and are therefore critical regulators of osteoclast-mediated bone
resorption (reviewed by Walsh and Choi, 2014). Many scientists
believe that RANK/RANKL system is a target of choice for
therapies aiming at treating disorders associated with altered
bone remodeling, such as osteoporosis (reviewed by Matsumoto
and Endo, 2020). Clinical studies evaluating the suitability of
RANKL inhibition to treat postmenopausal osteoporotic women
have shown that denosumab, a human monoclonal antibody
that specifically neutralizes RANKL, significantly reduced the
incidence of vertebra and hip fractures, and improved patients
prognosis (reviewed by Dempster et al., 2012). Interestingly, the
critical role of RANKL in osteoclastogenesis has been conserved
throughout evolution, as increased expression of rankl triggered
an osteoporotic bone phenotype in medaka (To et al., 2012;
Table 1). In rankl transgenic fish, active osteoclasts were formed
ectopically and promoted bone resorption in mineralized arches
and vertebral bodies, in a way that resembles findings in human
osteoporosis. Besides phenotypical similarities, rankl-induced
ectopic osteoclasts were shown to derive from a subset of
macrophages that migrated and accumulated into the vertebral
column, and then interacted with osteoblast progenitors before
differentiating into bone resorbing osteoclasts (Phan et al.,
2020). Transcriptome profiling of Rankl-activated macrophages
revealed the differential expression of several osteoclast markers,
e.g., trap, ctsk, siglec15, nfatc1, tgfb1, and dap12, a situation
also observed in mammals (Phan et al., 2020 and references
therein). Another feature common to both fish and mammalian
OP models, is the similar response to genetic or chemical
inhibition of tnf α, which improved bone loss in both models,
by reducing ectopic osteoclast differentiation in a selective
manner (Phan et al., 2020). The rescue of OP phenotype by
bisphosphonates was also evaluated in adult medaka, and both
alendronate and etidronate inhibited osteoclast activity in a
dose-dependent manner upon rankl induction, thus contributing
to the maintenance of bone homeostasis and integrity. Rescue
by bisphosphonates was also reported in osteoporotic larvae
(Yu et al., 2016; Yu and Winkler, 2017). The morphological
changes that occurred in fish osteoclasts during treatment, e.g.,
formation of aggregates and fusion into giant multinucleated
cells, were remarkably similar to those seen in patients after
long-term treatment with bisphosphonates (Jobke et al., 2014)




Microgravity experienced by astronauts during spaceflights
reduces the mechanical loading on bones and triggers bone
loss, skeletal deterioration and imbalanced calcium metabolism
(Keller and Strauss, 1993; Turner, 2000). To better understand
these effects, animal models were sent to space or submitted
to microgravity, among them the zebrafish and the medaka
(Moorman et al., 1999; Shimada et al., 2005; Aceto et al., 2016).
Larval zebrafish responded to microgravity by reducing otolith
(mineralized rods of the inner ear) development but also by
altering the expression of genes important for the development
of the notochord, which participates in the patterning and
formation of the vertebral column (Moorman et al., 1999).
Simulated microgravity (SMG) by 2D-clinorotation for 5 days
significantly decreased bone formation in zebrafish larvae and
altered the expression of genes involved in bone metabolism and
formation but also genes associated with disorders in connective
tissue, skeleton and muscle (Aceto et al., 2016; Table 1).
Zebrafish embryos exposed to SMG at key developmental stages
developed long term skeletal effects such as a reduced ossification
and skeletal malformations (Edsall and Franz-Odendaal, 2014).
Adult medaka and transgenic larvae sent to the International
Space Station exhibited a decreased osteoblastic activity, an
increased osteoclastic activity and a reduced BMD, i.e., signs
of microgravity-induced osteoporosis (Chatani et al., 2015,
2016). Promoter activity and expression of several osteoclast
marker genes (e.g., trap, ctsk, and mmp9) were also stimulated
during spaceflight, indicating enhanced osteoclastic activity.
Interestingly, GC-related genes (e.g., fkbp5 and ddit4), known
to contribute to osteoblast and osteoclast genesis, were also
upregulated. In contrast, exposure of zebrafish to hypergravity
increased bone formation by modifying the expression profile
of important bone markers (Aceto et al., 2015) and altered
cartilage properties (Lawrence et al., 2021). Beside the possibility
to identify new genes involved in bone formation and response to
mechanical loading, hypergravity may also hold some potential
for research on osteoporosis.
OSTEOPENIA MODELS
Osteopenia is characterized by a mild reduction of BMD and
often leads to osteoporosis if not detected and corrected in
due course. Fish models with adaptive osteopenia (a low BMD
condition that evolved in some fish as an adaptive mechanism)
or induced osteopenia (a low BMD condition that is induced in
fish placed in a particular situation or exposed to compounds)
have been described and are detailed below. Antarctic fish of
the notothenioid family, in particular the channichthyids or
icefish, have evolved a weakly ossified skeleton in response
to their habitat and the need to increase their buoyancy in
the water column for feeding (Albertson et al., 2009; Eastman
et al., 2014). The reduction of the BMD in icefish, favored
throughout millions of years of evolution, exhibits characteristics
similar to human osteopenia and could hold important clues
for the better understanding of disease mechanisms. However,
the difficulty to grow and study icefish in captivity has hindered
their use as model organisms and their wide distribution in
research laboratories. Reduced BMD conditions that could mimic
osteopenia phenotype are also found in fish exposed to fasting
and intensive swimming, situations that frequently occur during

















TABLE 2 | Fields of application of teleost OP models.





Rescue OP phenotype ZF GC induced OP Liquiritigenin ID 114829 Alp, Trap Carnovali et al., 2020b
Baicalin ID 64982 [Rank-Rankl-Opg] pathway Zhao et al., 2020
Icariin ID 5318997 N/A Wang et al., 2019
Tanshinol ID 126071 alp, runx2a, oc, sp7/ROS Luo S. et al., 2016
Salvianolic acid B ID 11629084 alp, runx2a, oc, sp7/ROS Luo S. Y. et al., 2016
Hydroxysafflor yellow A ID 6443665 alp, acp5, runx2, opg, oc Liu L. et al., 2018
Evodiamine ID 442088 Alp/[Mmp3-Opn-Mapk] pathway Yin et al., 2019
Shiitake mushroom EAE Nfatc1 Lee H. et al., 2020
Citrofulvicin ID 139591155 N/A Chen et al., 2018
Fulvionol ID 139591156
Zuogui pill Herb formula Alp, Trap, Tgf-β, p-Smad3, Col1/2 Yin et al., 2018
Xian-ling-gu-bao Herb formula N/A Wu et al., 2017
ZF glucose induced OP Liquiritigenin ID 114829 Alp, Trap Carnovali et al., 2019b
MK rankl-induced OP Delphinidin ID 68245 N/A Imangali et al., 2020
Icariin ID 5318997 N/A Pham et al., 2020
Bioprospection Identification of anti-OP
compounds/matrix
ZF GC induced OP Sinomenium acutum Dried stems/rhizomes Extracts and alkaloids Liu et al., 2020
Dunaliella salina Protein hydrolysates alp, runx2α, oc, sod, cat/P32 Chen et al., 2021
Dipsacus asperoides Dried root EAE Saponins and non-saponins Jing et al., 2014
Morinda officinalis Purified-derived
compounds
Anthraquinones, iridoid glycoside and
saccharides
Fu et al., 2020
Achyranthes bidentata Blume Polysaccharides from
CE
Peptide AB50 and ABPB-3 Zhang W. et al., 2018;
Yan et al., 2019
Abeliophyllum distichum Nakai Fruits, branches, and
leaves EE
Leaves EE Lee K. et al., 2020
Erxian decoction ID 72819117 Matrix of 13 compounds Wang et al., 2019
Ligustilide ID 5319022 N/A Yang et al., 2019
Cycloastragenol ID 13943286 N/A Wu et al., 2020
Acaulium sp. H-JQSF N/A Acaulins A and B Wang et al., 2018a,b
Pharmacology Rescue OP phenotype ZF GC induced OP Tigecycline ID 54686904 Mmp9 Kim et al., 2019
Minocycline ID 54675783




Hepcidin ID 91864521 runx2a, runx2b, oc Jiang et al., 2019
Deferoxamine ID 2973 alp, runx2a, runx2b, oc, op, col1/ROS Chen M. et al., 2014
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the migration of fishes such as eels and salmonids (Kacem and
Meunier, 2003; Rolvien et al., 2016). Under these conditions of
severe physiological stress, bone demineralization occurs through
a mechanism that may involve the action of glucocorticoids
and the activation of the neuroendocrine axis (Suarez-Bregua
et al., 2018). In this regard, a continuous exposure of zebrafish
larvae to parathyroid hormone resulted in a marked decrease
of bone mineralization after 6 days of treatment (Fleming et al.,
2005). Under appropriate conditions of stress (e.g., fasting), fish
could develop an osteoporotic phenotype resembling human
disease that could contribute to a better understanding of bone
demineralization (Schartl, 2014). Restricted mobility, i.e., limited
swimming activity, was also used to induce osteopenia in adult
zebrafish (Table 1). Upon movement restriction and decreased
mechanical loading, the shape of the vertebrae and the thickness
of the intervertebral space were altered, while bone volume and
density were reduced (Khajuria and Karasik, 2020). Following a
mechanism that may be related to reduced mechanical loading
but also to disrupted nerve function, the transient paralysis of
zebrafish muscle upon Botulinum toxin injection also impaired
intramembranous ossification during caudal fin regeneration
(Recidoro et al., 2014).
FRACTURE OSTEOPOROSIS MODELS
Several teleost skeletal structures—skull, fin and scales—have
been used to better understand the fracture-healing processes
and identify therapeutic agents (Sousa et al., 2012; Geurtzen
et al., 2014; Kobayashi-Sun et al., 2020). Although osteoblasts
were found to play a major role in fracture healing in both
mammals and teleosts, their origin seems to be different in
these two groups of vertebrates. In zebrafish, mature osteoblasts
will dedifferentiate in more proliferative and active cells during
the repair of fin fractures and skull injuries, a mechanism also
observed during fin regeneration (Geurtzen et al., 2014), while a
new set of osteoblasts is formed in mammals from mesenchymal
stem cells to contribute to the repair of bone injuries (Park et al.,
2012). Also conserved throughout evolution, the detrimental
effect of GCs on fracture healing was observed in mouse (Liu
Y. Z. et al., 2018) and in teleosts, delaying skull repair in
zebrafish (Geurtzen et al., 2017) and fin repair in medaka (Azetsu
et al., 2019), probably due to impaired osteoblast recruitment.
A recent study using zebrafish scale fracture model, reported
that osteoclast differentiation during fracture healing is mediated
by extracellular vesicles released by osteoblasts (Kobayashi-Sun
et al., 2020). Although the conservation of this mechanism in
mammals remains to be confirmed, data collected in teleosts shed
some light on a possible alternative process toward bone repair.
APPLICATIONS
Validated teleost OP models (Table 1) have been used in a
wide range of applications. The literature associated with these
applications has been expanding rapidly, with many publications
exploring disease mechanisms and others discovering novel
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therapeutic targets and compounds to treat disease symptoms.
Most of these studies used zebrafish GIOP model, probably
because it is a model that can be easily implemented in any
laboratory, but also because it addresses the most prevalent
type of secondary osteoporosis (Compston, 2018). However, the
importance of the other teleost OP models was not disregarded,
as they have allowed to unveil many conserved aspects of OP
pathology. Below are examples of the most popular applications
using teleost OP models (see also Table 2).
Anti-OP Compound Validation
Many extracts and compounds derived from plants and
herbs are commonly used worldwide as nutraceuticals and
largely explored in traditional Chinese medicine (TCM),
because of their antioxidant, anti-inflammatory, anti-tumoral,
neuro-protective, anti-diabetic, anti-angiogenic and anti-
atherosclerotic proprieties (Che et al., 2016). Several of these
natural extracts/compounds have also been claimed to have anti-
resorptive and bone anabolic activities, but strong scientific data
was missing to validate these claims. Glucocorticoid and glucose-
induced OP (zebrafish) and rankl-induced OP (medaka) are the
disease models that have been used to confirm their osteoactivity
and identify their mechanisms of action. For example, anti-
resorptive properties of the flavonoids liquiritigenin (Carnovali
et al., 2019b, 2020b), baicalin (Zhao et al., 2020), icariin (Wang
et al., 2019; Pham et al., 2020), and the pigment delphinidin
(Imangali et al., 2020) was shown to occur through impaired
osteoclast activity and reduced bone resorption. Other phenolic
compounds, such as tanshinol (Luo S. et al., 2016) and salvianolic
acid B (Luo S. Y. et al., 2016), were shown to have bone anabolic
properties, and hydroxysafflor yellow A was found to have
both bone anabolic and anti-resorptive properties (Liu L. et al.,
2018). The ability of alkaloids such as evodiamine (Yin et al.,
2019) to trigger bone remodeling and the capacity of fungal
extracts—e.g., from shiitake mushroom (Lee H. et al., 2020) and
from Penicillium velutinum (Chen et al., 2018)—to successfully
rescue OP phenotype was successfully demonstrated in the
zebrafish GIOP model. Osteoactivity of the TMC formulations
Xian-ling-gu-bao (Wu et al., 2017) and Zuogui pill (Yin et al.,
2018), commonly used in Asiatic countries to treat primary OP,
was also addressed in the zebrafish GIOP model, unveiling their
potential to also counteract secondary forms of OP.
Bioprospection
It is clear from the previous paragraph that natural extracts
contain promising osteoactive compounds that may be used to
develop next-generation drugs to treat osteoporosis. Because they
bring many technical advantages into the cumbersome screening
process, e.g., they allow larger and quicker screening assays,
teleost OP models, in particular the zebrafish GIOP model,
have been favored as first line screening assays and several
osteogenic fractions and compounds derived from plants and
fungi have already been identified (Niu et al., 2015; Lee K.
et al., 2020). Holistic approaches coupling network pharmacology
modulation and zebrafish GIOP model as a screening platform
to test the efficacy of identified matrixes were also successfully
implemented. These allowed, for example, to isolate osteogenic
enriched extracts derived from Erxian decoction (Wang et al.,
2019), osteogenic alkaloids extracts from S. acutum (Liu et al.,
2020), but also osteogenic peptides, polysaccharides and other
anabolic compounds from microalgae (Chen et al., 2021) and
plants (Zhang S. et al., 2018; Yan et al., 2019; Fu et al., 2020).
Teleost OP models were also used to screen natural compound
libraries and unveil new activities for old compounds (Yang et al.,
2019; Wu et al., 2020).
Pharmacology
Pharmaceuticals unrelated to OP treatment have been found to
have osteoactive properties in teleost OP models. For example,
tetracycline analogs—a well know class of antibiotics—were
shown in zebrafish GIOP model to prevent OP phenotype
(Kim et al., 2019). Long-chain fatty acid amides were found
to stimulate bone formation in the same model (Carnovali
et al., 2016b). Hepcidin, a protein involved in the regulation
of iron levels in blood, and deferoxamine, a drug that
binds circulating iron, were able to rescue iron overload
induced bone loss and to increase bone formation in zebrafish
(Chen B. et al., 2014; Jiang et al., 2019). Another example
that illustrates the diversity of the applications for teleost
OP systems was the use of goldfish scales to confirm the
ability of melatonin to prevent bone loss in a microgravity
environment. Melatonin, previously shown to improve bone
mass in postmenopausal osteopenic women (Amstrup et al.,
2015), was effective in suppressing goldfish osteoclast activity
during a space flight experiment, indicating that it could be a
promising treatment for bone loss experienced by astronauts
(Ikegame et al., 2019).
Omics
The global analysis of gene expression and protein production
is an important approach to unveil the genes, pathways
and proteins involved in disease development and treatment,
and to identify putative therapeutic targets. In this sense,
transcriptomic and proteomic analyses were applied to zebrafish
exposed to GCs followed by treatment with different bone
anabolic compounds, resulting in the identification of several
possible therapeutic targets, thus potentially opening new
routes for OP treatment (Chen et al., 2017; Lin et al.,
2019; Schmidt et al., 2019; Fu et al., 2020; Liu et al.,
2020).
Ecotoxicology
A less obvious, but not less important application of teleost
OP models, is their use as ecotoxicology tools. Synthetic GCs
(e.g., prednisolone and dexamethasone) have been detected in
the aquatic environment and the biological significance of this
contamination has raised serious concerns. Zebrafish was used
to confirm that environmental concentrations of GCs have
the capacity to alter the expression of genes involved in GCs
associated pathways and may potentiate disease mechanism
(Chen et al., 2016, 2017), raising public awareness to a
problem that may also impact on human (bone) health.
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In addition to the above-mentioned models, morphants, stable
knockdown and mutant zebrafish lines displaying phenotypic
features that partially mimic OP are available (they have been
extensively discussed by Laizé et al., 2014; Bergen et al., 2019;
Carnovali et al., 2019a; Tonelli et al., 2020; Dietrich et al., 2021).
These models are valuable tools to study OP-related genes and
mechanisms associated with low BMD and fragile bones, and
can be used in compound screening assays. Relevant examples
in zebrafish are the atp6v1h mutant, which exhibits a severe
reduction in the number of mature osteoblasts and an increase in
mmp9 and mmp13 expression (Zhang et al., 2017), the bmp1 frilly
fins (Asharani et al., 2012) and col1a1 chihuahua (Fisher et al.,
2003) mutants, which show general defects in bone growth that
lead to weak bones prone to fractures, the gpr137ba mutant (Urso
et al., 2019) characterized by an increased bone resorption, the
gba1 morphant (Zancan et al., 2015) characterized by impaired
osteoblast differentiation and reduced bone mineralization, and
the sp7 mutant (Kague et al., 2016) presenting a delayed bone
maturation and unregulated bone formation. On a different
aspect, the use of teleost systems to study gene-specific effects
upon pharmacological manipulation holds a great potential for
the screening of anti-OP compounds. For example, SOST is a
protein secreted in human by the osteocytes (Delgado-Calle et al.,
2017), and its mutated form was associated to high bone mass
(HBM) disorders (Balemans et al., 2001). By inhibiting SOST
binding to LRP5/6, the monoclonal antibody romosozumab
could stimulate bone deposition and improve OP patients’
condition (McClung, 2018). Interestingly, bone remodeling
in zebrafish and medaka is also mediated by sost, although
not expressed by osteocytes, and the down-regulation of sost
expression resulted in more bone deposited (Ofer et al., 2019).
Thus teleosts could be used for large screening assays aiming
at identifying compound that could modulate sost expression
toward an increased bone deposition. A similar example is
associated with the modulation of smad9 expression in zebrafish
(Gregson et al., 2020; McDonald et al., 2021). These two examples
highlight the evolutionary conservation of skeletal mechanisms
from fish to human and reinforce the suitability of teleost
models for target-based screening assays. Data from genome wide
association studies (GWAS) and human epidemiological analysis
of skeletal diseases represent a promising source of new targets to
be validated and further characterized in teleosts.
CONCLUSION
The high degree of conservation of the mechanisms involved in
skeletogenesis between fish and mammals allows to recapitulate,
with a notable similarity, OP phenotypes in zebrafish and
medaka, two small teleosts that can be incorporated in high-
throughput screening pipelines and thus hold great promises for
the discovery of anti-OP drugs. Among the different systems
described in this review, glucocorticoid-induced OP in zebrafish
is by far the most popular system, being easily operable in
most laboratories and necessitating only wild-type zebrafish lines.
Although the transgenic medaka line overexpressing rankl is
meant to gain more importance in the future as it represents
the most suited OP model developed so far, particular attention
should be given to fish HBM models currently being developed as
they provide an interesting alternative approach to classical OP
models that may prove to be more fruitful. The positive impact
of fish OP models on the identification of compounds with anti-
OP activity is already perceptible and is likely to gain momentum
in the next decade. Due to their enormous potential, it is also
possible that we see fish OP models becoming more prominent
models for pre-clinical OP studies.
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